Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.

International Brazilian Journal of Urology, published by the Brazilian Society of Urology, is a distinguished open-access journal that has been contributing to the field of urology since 2003. This journal plays a vital role in disseminating high-quality research and advancements in various aspects of urological science and medicine, targeting an international audience of researchers, practitioners, and students. With an impressive ranking in the 2023 Scopus metrics, securing Q2 status in both Medicine (Miscellaneous) and Urology, it stands as a significant resource for emerging trends and discoveries in these areas. The journal’s commitment to accessibility, with open access since its inception, ensures that valuable findings are readily available to the global medical community. Situated in Rio de Janeiro, Brazil, the International Brazilian Journal of Urology not only enhances academic discourse but also fosters collaboration across borders and specialties, making it a pivotal platform for advancing urological research.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.

Trends in Urology & Men's Health is a leading academic journal published by Wiley, dedicated to advancing the study of urology and men's health through innovative research and clinical insights. With its ISSN 2044-3730 and E-ISSN 2044-3749, this journal provides a platform for researchers, professionals, and students to explore the latest developments, trends, and methodologies in the field. The journal aims to promote interdisciplinary collaboration and knowledge sharing among healthcare practitioners, ensuring a comprehensive approach to men's health issues, including urological disorders and associated systemic conditions. Though it operates under subscription access, Trends in Urology & Men's Health remains vital for disseminating high-impact research, fostering educational advancement, and addressing critical health challenges facing men globally. Published from its headquarters at 111 River St, Hoboken, NJ, the journal stands as a significant resource for those engaged in urological research and practice.

Nature Reviews Urology, published by NATURE PORTFOLIO, stands as a leading journal in the field of urology, showcasing cutting-edge research and reviews that address the complexities and advancements within this dynamic medical specialty. With a 2023 impact factor that places it firmly in the Q1 quartile of urology journals, it ranks impressively within the top 3 out of 120 in Scopus, highlighting its critical role in disseminating significant academic findings. As a premier source of scholarly information, this journal aims to provide urology professionals, researchers, and students with comprehensive insights into the latest clinical practices, therapeutic developments, and technological innovations, promoting a deeper understanding of urological conditions. The journal also ensures accessibility to its articles, demonstrating a commitment to the open dissemination of knowledge essential for advancing urology research and practice.

PROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.

Prostate International is a leading open-access journal published by Elsevier Inc, dedicated to advancing research and knowledge in the field of urology, particularly focusing on prostate health and disease. Since its inception in 2013, the journal has preserved its commitment to disseminating high-quality, peer-reviewed articles that contribute significantly to clinical practices and scientific understanding. With an impressive Q1 ranking in urology and a current position as rank #35/120 among urology journals in Scopus, it occupies a prominent place in the academic landscape, ensuring that cutting-edge research reaches a broad audience. The journal's open-access policy enhances visibility and accessibility, fostering collaboration among researchers, healthcare professionals, and students. With the range of topics covered, from innovative treatments to diagnostic advancements, Prostate International serves as a vital resource for those committed to improving patient outcomes and driving the future of urological health.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

Revista Internacional de Andrologia, published by Elsevier España SLU, is a pivotal academic journal advancing the field of andrology, particularly focusing on reproductive medicine and urology. With an ISSN of 1698-031X and recognized as a reputable source within the medical community, this journal holds a Q3 ranking in both Reproductive Medicine and Urology as of 2023, reflecting its significant contribution to the field. Researchers and professionals are encouraged to engage with a diverse range of articles published annually, offering insights into current trends, innovative methodologies, and emerging challenges. Although the journal is not open access, it is an essential resource for those seeking to stay at the forefront of research and practice in andrology, making it a valuable tool for academics and clinicians alike. As the journal progresses through its converged years from 2005 to 2024, it remains committed to fostering collaboration and knowledge dissemination within the global medical community.

ASIAN JOURNAL OF ANDROLOGY, published by Wolters Kluwer Medknow Publications, is a leading Open Access journal in the fields of urology and andrology. Since its inception in 1999, this journal has been instrumental in disseminating pivotal research that advances understanding and promotes progress within these specialty areas. With an impressive impact factor and a Scopus ranking of #27 out of 120 in Medicine (Urology), it is recognized for its contributions to both academia and clinical practice. The journal serves as a vital platform for researchers, professionals, and students interested in the latest findings and developments in male reproductive health and related fields, making it a key resource for anyone striving to enhance their knowledge and expertise. Based in India, the ASIAN JOURNAL OF ANDROLOGY is committed to fostering global discussions and collaborations that bind the scientific community together in the quest for innovation and improved patient outcomes.